Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Running, not enrolling · Phase 3

Conditions studied: Prostate Cancer

In brief

RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens. Radiation therapy uses high-energy x-rays to kill tumor cells. PURPOSE: This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer.

Key facts

Study ID
NCT01368588
Run by
Radiation Therapy Oncology Group
People needed
2590
Starts
2011-07-01
Expected to finish
2031-07-01
Last updated by the study team
2026-05-08

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.